Zomedica Pharmaceuticals (ZOM) has released an update.
Zomedica Pharmaceuticals has appointed Scott A. Jordan as Executive Vice President, Finance and Chief Financial Officer, starting January 1, 2025. With over 30 years of experience in the life sciences and diagnostics industries, Jordan’s strategic finance and business development skills are expected to drive Zomedica’s growth in the animal health sector. His extensive background includes founding S. Jordan Associates and holding key financial roles in biotechnology companies.
For further insights into ZOM stock, check out TipRanks’ Stock Analysis page.